Velta
Vertically integrated titanium producer supplying powder feedstock for additive manufacturing and producing finished medical implants via 3D printing; unique zero-waste Velta Ti Process reduces titanium production costs 4x vs conventional Kroll method.
- CEO / Founder
- Andriy Brodskyy
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- 3000000
- Latest Round
- Bootstrapped
- Key Investors
- European Lithium; Export-Import Bank of the United States
Technology & Products
Key Products
Titanium powder for additive manufacturing; Titanium feedstock (ilmenite concentrate); Custom 3D-printed titanium medical implants; Titanium metal and alloys (through Velta Ti Process)
Technological Advantage
Proprietary Velta Ti Process (patented 2020 for titanium metal, 2021 for alloys) reduces production costs 4x vs Kroll method industry standard; zero-waste process with environmental compliance; ability to scale from R&D powder (semi-industrial Dnipro facility) to full-scale production; seamless integration of feedstock supply with AM application minimizes supply chain friction.
Differentiation
Value Proposition
Supplies 2% of global titanium feedstock market at 4x lower cost than conventional methods via proprietary zero-waste Velta Ti Process; vertically integrated from mine to finished AM products eliminates supply chain intermediaries; capability to produce custom 3D-printed titanium medical implants on-demand.
How They Differentiate
Vertical integration from mining to finished products is rare in titanium supply chain; proprietary process cost advantage (4x reduction); zero-waste production vs conventional high-waste Kroll method; established R&D capability with patented alloy production; existing medical implant production via Velta Medical.
Market & Competition
Target Customers
AM companies, aerospace manufacturers, medical device makers, industrial companies requiring titanium feedstock or finished implants
Industry Verticals
Additive Manufacturing; Aerospace & Defense; Medical Devices; Industrial Manufacturing
Growth & Milestones
Growth Metrics
Holds 2% of global titanium feedstock market; commercial shipments began 2012; scaled from semi-industrial to supporting AM applications division; established Velta Medical division in 2023 for medical implant production.
Major Milestones
2006: Velta founded; 2011: Mining and processing complex completed in Kirovograd region (8-month construction, $90M investment); 2012: Commercial titanium feedstock shipments began; 2020: Velta Ti Process patented (titanium metal production); 2021: Velta Ti Process extension patented (titanium alloys); 2023: Velta Medical launched (3D-printed titanium medical implants); 2024: Third US patent received during wartime operations
Notable Customers
Chemours (DuPont), Precheza, Traxys